152. PCDH19 related syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 10 / Drugs : 7 - (DrugBank : 1) / Drug target genes : 16 - Drug target pathways : 7
PCDH19 related syndrome and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 152 | PCDH19 related syndrome | - |
| 36 | Epidermolysis bullosa | 16.000 |
| 144 | Lennox-Gastaut syndrome | 16.000 |
| 13 | Multiple sclerosis/Neuromyelitis optica | 16.000 |
| 193 | Prader-Willi syndrome | 16.000 |
| 6 | Parkinson disease | 16.000 |
| 21 | Mitochondrial disease | 16.000 |
| 2 | Amyotrophic lateral sclerosis | 16.000 |
| 75 | Cushing disease | 16.000 |
| 231 | Alpha-1-antitrypsin deficiency | 16.000 |
| 17 | Multiple system atrophy | 16.000 |
| 34 | Neurofibromatosis | 16.000 |
| 46 | Malignant rheumatoid arthritis | 16.000 |
| 84 | Sarcoidosis | 16.000 |
| 96 | Crohn disease | 16.000 |
| 98 | Eosinophilic gastrointestinal disease | 16.000 |
| 158 | Tuberous sclerosis | 16.000 |
| 8 | Huntington disease | 16.000 |
| 5 | Progressive supranuclear palsy | 16.000 |
| 156 | Rett syndrome | 16.000 |
| 272 | Fibrodysplasia ossificans progressiva | 16.000 |
| 298 | Hereditary pancreatitis | 16.000 |
| 97 | Ulcerative colitis | 16.000 |
| 206 | Fragile X syndrome | 16.000 |
| 296 | Biliary atresia | 16.000 |
| 22 | Moyamoya disease | 16.000 |
| 70 | Spinal stenosis | 16.000 |
| 140 | Dorabe syndrome | 16.000 |
| 3 | Spinal muscular atrophy | 16.000 |
| 145 | West syndrome | 16.000 |
| 201 | Angelman syndrome | 16.000 |
| 18 | Spinocerebellar degeneration | 16.000 |
| 205 | Fragile X syndrome related disease | 16.000 |
| 155 | Acquired aphasia with convulsive disorder | 16.000 |